Cholinergic stimulation of the lower esophageal sphincter in patients with vagotomy and antrectomy
- PMID: 1124744
- DOI: 10.1007/BF01070721
Cholinergic stimulation of the lower esophageal sphincter in patients with vagotomy and antrectomy
Abstract
Recently cholinergic stimulation of the lower esophageal sphincter (LES) with bethanechol has been shown to be effective in the treatment of chronic gastroesophageal reflux. Since chronic reflux and esophagitis also occur in patients with vagotomy and antrectomy, we studied the effect of bethanechol on sphincter pressure in 10 patients who had had vagotomy and antrectomy. Both subcutaneous (0.08 mg/kg) and oral (25 mg) administration of bethanechol caused significant increases in LES pressure in these patients. In addition, both subcutaneous and oral administration of bethanechol elevated hypotensive sphincter pressures to normal levels. Orally administered bethanechol produced a sustained increase in LES pressure throughout a 90-min study period. These studies suggest that cholinergic stimulation of the LES with bethanechol may be of therapeutic benefit in vagotomized and antrectomized patients with gastroesophageal reflux.
Similar articles
-
Lower esophageal sphincter pressures and serum gastrin levels after cholinergic stimulation.Am J Physiol. 1976 Oct;231(4):1250-3. doi: 10.1152/ajplegacy.1976.231.4.1250. Am J Physiol. 1976. PMID: 984209
-
Early effects of bethanechol on the esophageal motor function of infants with gastroesophageal reflux.J Pediatr Gastroenterol Nutr. 1986 Jan;5(1):47-51. doi: 10.1097/00005176-198601000-00009. J Pediatr Gastroenterol Nutr. 1986. PMID: 2868087
-
Effect of bethanechol on gastroesophageal reflux.Am J Dig Dis. 1977 Mar;22(3):230-4. doi: 10.1007/BF01072281. Am J Dig Dis. 1977. PMID: 842531
-
[Primperan and gastroesophageal reflux. Review of the literature].Ann Gastroenterol Hepatol (Paris). 1985 May 28;21(2 Pt 2):17-20. Ann Gastroenterol Hepatol (Paris). 1985. PMID: 3898989 Review. French.
-
Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy.Ann Intern Med. 1982 Jul;97(1):93-103. doi: 10.7326/0003-4819-97-1-93. Ann Intern Med. 1982. PMID: 6124198 Review.
Cited by
-
L-Dopa inhibits metoclopramide stimulation of the lower esophageal sphincter in man.Dig Dis Sci. 1979 Apr;24(4):289-95. doi: 10.1007/BF01296543. Dig Dis Sci. 1979. PMID: 378623 Clinical Trial.